Plant Path
San Diego, United States· Est.
Is this your company? Claim your profile to update info and connect with investors.
Claim profilePrivate Company
Funding information not available
Overview
Produces infectious disease antibodies and biologics using a scalable plant-based manufacturing platform.
Infectious Disease
Technology Platform
A plant-based expression system for the rapid, scalable, and cost-effective production of complex therapeutic proteins and antibodies.
Opportunities
Potential to revolutionize biologics manufacturing for pandemic preparedness and lower-cost therapeutics in emerging markets.
Risk Factors
Regulatory uncertainty and potential public perception issues around plant-derived pharmaceuticals pose adoption challenges.
Competitive Landscape
Competes with large biopharma using mammalian cell culture and other niche biotech platforms like yeast or insect cell systems.